Leronlimab is on clinical hold because it poses a
Post# of 151591
(Total Views: 766)
Posted On: 05/12/2022 2:51:49 PM
Leronlimab is on clinical hold because it poses a threat to BP revenue.
If this were about safety concerns, the FDA would never have approved Remdesivir.
If this were about safety concerns, the FDA would never have approved mRNA vaccines for babies, children, teens, and pregnant women.
The FDA narrative claims LL safety concerns?
No credibility.
If this were about safety concerns, the FDA would never have approved Remdesivir.
If this were about safety concerns, the FDA would never have approved mRNA vaccines for babies, children, teens, and pregnant women.
The FDA narrative claims LL safety concerns?
No credibility.
(13)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼